A difficult-to-treat pleuropulmonary histoplasmosis in a patient with rheumatoid arthritis in Taiwan
Amphotericin B and itraconazole are the primary agents for treating histoplasmosis. Newer azoles are alternatives for patients refractory to or intolerant of standard therapy. We report an 83-year-old woman with rheumatoid arthritis complicated with pleuropulmonary histoplasmosis who responded to li...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier
2023-02-01
|
| Collection: | Journal of Microbiology, Immunology and Infection |
| Sujets: | |
| Accès en ligne: | http://www.sciencedirect.com/science/article/pii/S1684118222002869 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|